What is it used for?
KINERET is indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis (RA), in patients 18 years of age or older who have failed 1 or more disease modifying antirheumatic drugs (DMARDs). KINERET can be used alone or in combination with DMARDs other than Tumor Necrosis Factor (TNF) blocking agents . KINERET is indicated for the treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID). KINERET is indicated for the treatment of Deficiency of Interleukin-1 Receptor Antagonist (DIRA)KINERET is indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis (RA), in patients 18 years of age or older who have failed 1 or more disease modifying antirheumatic drugs (DMARDs). KINERET can be used alone or in combination with DMARDs other than Tumor Necrosis Factor (TNF) blocking agents . KINERET is indicated for the treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID). KINERET is indicated for the treatment of Deficiency of Interleukin-1 Receptor Antagonist (DIRA)
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- anakinraanakinra
- Form and strength
- INJECTION, SOLUTION · 100 mg / 0.67 mLINJECTION, SOLUTION · 100 mg / 0.67 mL
- Manufacturer / applicant
- SWEDISH ORPHAN BIOVITRUM AB (PUBL)SWEDISH ORPHAN BIOVITRUM AB (PUBL)
Injection: 100 mg/0.67 mL solution in a single-use prefilled syringe for subcutaneous injection. Graduated syringe allows for doses between 20 and 100 mg.Injection: 100 mg/0.67 mL solution in a single-use prefilled syringe for subcutaneous injection. Graduated syringe allows for doses between 20 and 100 mg.
Safety and clinical review
- Serious InfectionsSerious Infections
- Use with TNF Blocking AgentsUse with TNF Blocking Agents
- Hypersensitivity ReactionsHypersensitivity Reactions
- ImmunosuppressionImmunosuppression
- AmyloidosisAmyloidosis
- ImmunizationsImmunizations
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is Kineret used for?
KINERET is indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis (RA), in patients 18 years of age or older who have failed 1 or more disease modifying antirheumatic drugs (DMARDs). KINERET can be used alone or in combination with DMARDs other than Tumor Necrosis Factor (TNF) blocking agents . KINERET is indicated for the treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID). KINERET is indicated for the treatment of Deficiency of Interleukin-1 Receptor Antagonist (DIRA)KINERET is indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis (RA), in patients 18 years of age or older who have failed 1 or more disease modifying antirheumatic drugs (DMARDs). KINERET can be used alone or in combination with DMARDs other than Tumor Necrosis Factor (TNF) blocking agents . KINERET is indicated for the treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID). KINERET is indicated for the treatment of Deficiency of Interleukin-1 Receptor Antagonist (DIRA)
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of Kineret should I ask about?
INJECTION, SOLUTION · 100 mg / 0.67 mLINJECTION, SOLUTION · 100 mg / 0.67 mL
Read the primary sourceWhat determines the price of Kineret?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using Kineret?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.